23 May 2013
Keywords: betafectin, data, support, trial, continuation, alpha-beta, technology
Article | 30 April 1998
Alpha-Beta Technology says that, following an interim review of datafrom the first 98 patients, it plans to continue a Phase II ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.